Investor Sphera Funds Management Ltd.
13D/G Filings

This page shows a list of all the recent 13D/G filings made by Sphera Funds Management Ltd. . Schedule 13D is commonly referred to as a “beneficial ownership report.” The term "beneficial owner" is defined under SEC rules. It includes any person who directly or indirectly shares voting power or investment power (the power to sell the security).

When a person or group of persons acquires beneficial ownership of more than 5% of a voting class of a company’s equity securities, they are required to file a Schedule 13D within ten days after the purchase. Click the link icon to see the full transaction history.

Add This Fund
to your dashboard

Date Form Target Prev
Shares		 Current
Shares		 Change
(Percent)		 Ownership
(Percent)		 Change
(Percent)
2025-04-10 13G/A OTLK / Outlook Therapeutics, Inc. 1,714,284 2,571,426
2025-04-10 13G/A SKYE / Skye Bioscience, Inc. 1,301,518 1,476,353
2025-04-10 13G/A CMMB / Chemomab Therapeutics Ltd. - Depositary Receipt (Common Stock) 1,214,575 900,428
2025-03-03 13G OTLK / Outlook Therapeutics, Inc. 1,714,284
2024-11-04 13G/A JSPR / Jasper Therapeutics, Inc. 189,270
2024-08-20 13G CMMB / Chemomab Therapeutics Ltd. - Depositary Receipt (Common Stock) 1,214,575
2024-02-08 13G SKYE / Skye Bioscience, Inc. 1,301,518
2024-02-05 13G/A / JASPER THERAPEUTICS INC 5,687,134 7,130,625
2024-02-05 13G/A PRAX / Praxis Precision Medicines, Inc. 8,764,334 328,986
2024-02-05 13G/A INZY / Inozyme Pharma, Inc. 2,096,258 1,562,907
2024-02-05 13G/A PMN / ProMIS Neurosciences, Inc. 1,852,518 1,892,474
2023-10-10 13G / JASPER THERAPEUTICS INC 5,687,134
2023-08-30 13G PMN / ProMIS Neurosciences, Inc. 1,852,518
2023-06-27 13G/A PRAX / Praxis Precision Medicines, Inc. 8,764,334 8,764,334
2023-06-22 13G PRAX / Praxis Precision Medicines, Inc. 8,764,334
2023-03-07 13G INZY / Inozyme Pharma, Inc. 2,096,258
2023-02-06 13G/A CYCC / Cyclacel Pharmaceuticals, Inc. 508,322 250,000
2022-02-14 13G/A ALT / Altimmune, Inc. 3,775,618 1,244,241
2022-02-14 13G/A CYCC / Cyclacel Pharmaceuticals, Inc. 506,824 508,322
2021-08-31 13G ALT / Altimmune, Inc. 3,775,618
2021-03-18 13G CYCC / Cyclacel Pharmaceuticals, Inc. 506,824
2021-02-16 13G/A LRMR / Larimar Therapeutics, Inc. 2,836,367 0
2021-02-16 13G/A ORGS / Orgenesis Inc. 1,123,090 525,216
2021-02-16 13G/A SIOX / Sio Gene Therapies Inc. 2,931,017 0
2021-02-16 13G/A XFOR / X4 Pharmaceuticals, Inc. 970,000 250,000
2021-02-16 13G/A US64052L1061 / Neos Therapeutics, Inc. 3,530,731 0
2021-02-16 13G/A ALLT / Allot Ltd. 1,808,196 1,129,054
2020-02-25 13G/A SIOX / Sio Gene Therapies Inc. 398,540 2,931,017
2020-02-11 13G LRMR / Larimar Therapeutics, Inc. 2,836,367
2020-02-11 13G/A VTGN / Vistagen Therapeutics, Inc. 2,788,867 1,314,949
2020-02-11 13G/A XFOR / X4 Pharmaceuticals, Inc. 845,000 970,000
2020-02-11 13G/A SIOX / Sio Gene Therapies Inc. 8,200,000 398,540
2020-02-11 13G/A US64052L1061 / Neos Therapeutics, Inc. 3,711,454 3,530,731
2020-02-11 13G/A ALLT / Allot Ltd. 1,790,196 1,808,196
2020-02-11 13G EVOK / Evoke Pharma, Inc. 1,410,946 0
2020-01-28 13G ORGS / Orgenesis Inc. 1,123,090
2019-12-31 13G ALLT / Allot Ltd. 1,790,196
2019-12-23 13G XFOR / X4 Pharmaceuticals, Inc. 845,000
2019-07-02 13G US64052L1061 / Neos Therapeutics, Inc. 3,711,454
2019-02-13 13G/A EIGR / Eiger BioPharmaceuticals, Inc. 511,469 87,189
2019-02-13 13G/A VKTX / Viking Therapeutics, Inc. 2,145,300 770,727
2019-02-13 13G/A VTGN / Vistagen Therapeutics, Inc. 2,182,712 2,788,867
2019-02-13 13G/A ALDX / Aldeyra Therapeutics, Inc. 1,159,131 1,232,089
2018-12-20 13G SIOX / Sio Gene Therapies Inc. 8,200,000
2018-05-08 13G EVOK / Evoke Pharma, Inc. 1,410,946
2018-02-13 13G/A MRNS / Marinus Pharmaceuticals, Inc. 1,340,588 0
2018-02-13 13G/A ALDX / Aldeyra Therapeutics, Inc. 783,500 1,159,131
2018-02-13 13G/A VTGN / Vistagen Therapeutics, Inc. 838,200 2,182,712
2018-02-13 13G/A EIGR / Eiger BioPharmaceuticals, Inc. 447,609 511,469
2017-12-18 13G VKTX / Viking Therapeutics, Inc. 2,145,300
2017-08-22 13G EIGR / Eiger BioPharmaceuticals, Inc. 447,609
2017-02-21 13G ALDX / Aldeyra Therapeutics, Inc. 783,500
2017-02-13 13G/A MRNS / Marinus Pharmaceuticals, Inc. 1,170,643 1,340,588
2017-02-13 13G/A / Achaogen Inc 1,571,708 514,342
2017-01-24 13G/A VTGN / Vistagen Therapeutics, Inc. 588,200 838,200
2016-07-06 13G MRNS / Marinus Pharmaceuticals, Inc. 1,170,643
2016-06-22 13G VTGN / Vistagen Therapeutics, Inc. 588,200
2016-06-13 13G / Achaogen Inc 1,571,708
2015-02-26 13G/A ELLO / Ellomay Capital Ltd. 454,490
2015-01-15 13G/A ELLO / Ellomay Capital Ltd. 563,090
2014-12-02 13G ELLO / Ellomay Capital Ltd. 558,350
2013-08-15 13G/A ELLO / Ellomay Capital Ltd. 496,955
2013-08-05 13G ELLO / Ellomay Capital Ltd. 622,300